Drugs / supramolecular salicylic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06925035 | Jun → Dec 2023 | skin disorder | Second Affiliated Hospital of Xi'an Jiaotong University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | supramolecular salicylic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06925035 ↗ |
| Known as | SSA | “supramolecular salicylic acid(SSA)” NCT06925035 ↗ |
| Route | Topical | “were randomly assigned to be applied on one side of the face” NCT06925035 ↗ |